Companies
Molbio Diagnostics
Truenat — Battery-operated real-time PCR.
- Country
- India
point-of-care
in
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| diagnostics-medtech | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Revenue | Rs 1,455.17 crore (FY26) (2026-03-31) | blog.fintoo.in · entrackr.com · mywealthpost.com |
| Headcount | 1,225 payroll employees and 1,615 contract workers (2026-03-31) | assets.ipopremium.in · blog.fintoo.in · entrackr.com · mywealthpost.com |
| Capacity | 5,400 devices and 39 million test kits per year (2026-03-31) | blog.fintoo.in · mywealthpost.com |
| Production site | Six manufacturing facilities: two in Goa, one in Bengaluru, one in Vizag, one Prognosys plant in Bengaluru, and one OptraScan plant in Pune (2026-08-31) | blog.fintoo.in · mywealthpost.com |
| Funding | Rs 939.70 crore IPO (fresh issue of Rs 200 crore) (2026-08-31) | entrackr.com · medicalbuyer.co.in · mywealthpost.com |
| Certification | ICMR certification and WHO endorsement for TB test kits (2026-03-31) | blog.fintoo.in · mywealthpost.com |
| Regulatory approval | US FDA 510(k) clearance for OptraSCAN system (2026-07-20) | molbiodiagnostics.com |
Independent sources: assets.ipopremium.in · blog.fintoo.in · entrackr.com · medicalbuyer.co.in · mywealthpost.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Diagnostics & biosensors | diagnostics-medtech | Low | → |
| Point-of-care molecular diagnostics | diagnostics-medtech | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.